StemInov raises €10.6 million to accelerate its industrial and clinical development

​

This financing will enable StemInov to scale up the industrialization of its stem cell-based technology and prepare the clinical entry of its breakthrough therapy for severe pneumonia – a life-threatening condition with no specific treatment available today.